awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38167808-35F4E20D-0FA2-4BEE-B6E8-05FD28FE674F
Q38167808-35F4E20D-0FA2-4BEE-B6E8-05FD28FE674F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38167808-35F4E20D-0FA2-4BEE-B6E8-05FD28FE674F
Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer.
P2860
Q38167808-35F4E20D-0FA2-4BEE-B6E8-05FD28FE674F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38167808-35F4E20D-0FA2-4BEE-B6E8-05FD28FE674F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e39e9ab534a71d462fc3f883d7aab53ba426128
P2860
Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia